2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

TA McDonagh, M Metra, M Adamo… - European heart …, 2021 - academic.oup.com
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Cancer and heart disease: associations and relations

RA de Boer, WC Meijers, P van der Meer… - European journal of …, 2019 - Wiley Online Library
Emerging evidence supports that cancer incidence is increased in patients with
cardiovascular (CV) disease and heart failure (HF), and patients with HF frequently die from …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Diretriz brasileira de insuficiência cardíaca crônica e aguda

LEP Rohde, MW Montera, EA Bocchi… - Arq. bras …, 2018 - pesquisa.bvsalud.org
A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …

Cardiovascular risk factors are associated with future cancer

ES Lau, SM Paniagua, E Liu, M Jovani, SX Li… - Cardio Oncology, 2021 - jacc.org
Background The extent to which co-occurrence of cardiovascular disease (CVD) and cancer
is due to shared risk factors or other mechanisms is unknown. Objectives This study …

Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association …

RA de Boer, JS Hulot, CG Tocchetti… - European journal of …, 2020 - Wiley Online Library
The co‐occurrence of cancer and heart failure (HF) represents a significant clinical
drawback as each disease interferes with the treatment of the other. In addition to shared …

Heart failure stimulates tumor growth by circulating factors

WC Meijers, M Maglione, SJL Bakker, R Oberhuber… - Circulation, 2018 - Am Heart Assoc
Background: Heart failure (HF) survival has improved, and nowadays, many patients with HF
die of noncardiac causes, including cancer. Our aim was to investigate whether a causal …

[PDF][PDF] Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda

CCD De Insuficiência, C Colaboradores… - Arq Bras Cardiol, 2018 - SciELO Brasil
A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors

N Bansal, MJ Adams, S Ganatra, SD Colan… - Cardio-Oncology, 2019 - Springer
Cancer diagnostics and therapies have improved steadily over the last few decades,
markedly increasing life expectancy for patients at all ages. However, conventional and …

Linking heart failure to cancer: background evidence and research perspectives

E Bertero, M Canepa, C Maack, P Ameri - Circulation, 2018 - Am Heart Assoc
Recent epidemiological analyses suggest that incident cancer may be more common
among patients with preexisting heart failure (HF) than in patients without HF. Arguments …